Awarded
Enfortumab vedotin 30 mg in 3 ml Fertiglsg. Pulver für ein Konzentrat zur Herstellung einer Infusionslösung St
- Buyer
- PBMG eG
- Winners
- ASTELLAS PHARMA GMBH GERMANY
- Contract value
- no value published
- Bids received
- 1
- Published
- 2 Mar 2026
- Awarded
- 30 Dec 2025
- Contract start
- 1 Jul 2026
- Contract end
- 31 Dec 2026stated
- Region
- Hamburg (DE600)